(Q40855750)

24 September 2017

0 references

Hsp90 inhibitors: a potential treatment for latent EBV infection? (English)

1 reference

24 September 2017

Xiaoping Sun

1

1 reference

PMC publication ID

2879875

24 September 2017

Shannon C Kenney

series ordinal

2

1 reference

24 September 2017

19 May 2010

1 reference

24 September 2017

1 reference

24 September 2017

9

1 reference

24 September 2017

9

1 reference

24 September 2017

1665-1666

1 reference

Hsp90 inhibitors block outgrowth of EBV-infected malignant cells in vitro and in vivo through an EBNA1-dependent mechanism.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879875

Purine-scaffold Hsp90 inhibitors.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879875

Targeting Hsp90: small-molecule inhibitors and their clinical development

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879875

Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879875

The plasmid replicon of Epstein-Barr virus: mechanistic insights into efficient, licensed, extrachromosomal replication in human cells.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879875

Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879875

Interaction of Hsp90 with ribosomal proteins protects from ubiquitination and proteasome-dependent degradation

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879875

A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879875

Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879875

Identification and structural characterization of the ATP/ADP-binding site in the Hsp90 molecular chaperone

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879875

Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2879875

19 August 2018

Identifiers

DOI

10.4161/CC.9.9.11594

1 reference

24 September 2017

1 reference

PMC publication ID

2879875

24 September 2017

PubMed publication ID

20404505

1 reference

PMC publication ID

2879875